{"name":"Edgewise Therapeutics, Inc.","slug":"edgewise-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":151389000,"netIncome":-167795000,"cash":61148000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOUDhWckF2QjJCcUVrQ09yYWR3NGVvN0tEdXpZR2JtQWdDV25fNjhQVDRsMEs4SUVmcXhFcGJHdjhtV1NxX1lUNFZ5OHlQb2M5bS1QekoxSkhoVEpnU0ZVWEI2dWNiZ2lIa3JiRmViZVdEUm1EZ3A2a1FpaTIwdEU2dVdUTzdrQjJaV3hEdVVrTmNzek13eVk1d0Z5WWxKOElkLXp5a0lsYUlQNFZLR2h3bHdrOU9OMEJUcXZZWU9UZEtDWGFUNWlmR19XZUU5UE1ZRFE2c2lLMWxVMm5s?oc=5","date":"2026-03-02","type":"pipeline","source":"PR Newswire","summary":"Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PR Newswire","headline":"Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules","sentiment":"neutral"},{"date":"2026-02-26","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-02-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxPTlRrRjBVOGpGNzI0RGI2Szk0SGtIRE9kR3hwbWEtblF3SW1sd0ZRQVhwOXBKWE5hd1ZpbWhpWm1JUml2enRzTGVnUXlnTUFhTENNY2hhQ3FGWkgza1N5aHpYZ21NQ2hqcUZVLWs5bW5rTTh2VVpoUDFYRVl0MF9TZ19ZV2YxSU9ibGJfVV9qWlJ2dm91MFk5NEoxcHBNSFUzMTlmR3l2SkZyRUtoM0dvN2M1b3VDUUhXdlYwblFoTDFPXzVsaGtRNndBRVdnSjBvRXBQTXVFeU9ycDJjSWVJZFZyQ05XM2Rza210d29NYWhlR3ViSWZ0N19md1Fpemh0ZHRjLUl5NA?oc=5","date":"2026-01-30","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and COMPASS Pathways (CMPS) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and COMPASS Pathways (CMPS)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxPMXI4a2NNM2FPM183OU4wMjR5azhzNW1xM0VKRFpUMkdEQWJMVG5uUG1Cb3VyZEVTbWtfWDlTQy1sUjNHTmdSRE9vY2VpbXczdFZoVWFwcnNySHRfRkhhcXlKZzZvQkt0V3djV3hsUTA2ZFoyUTNrOUNZdDRIZ2tIMzE5bEExVGx0Uk9Cd1VRS1h3a0wwblhhZDhxUmVIQ2JVVFJGQzVxWlRvT3JieEVaMFY2TTMxVFg2al9RcTRPNHJNUkhRcVM1ZmFsR1hiTEIyTDM0ZDB3?oc=5","date":"2026-01-13","type":"pipeline","source":"PR Newswire","summary":"Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026 - PR Newswire","headline":"Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPdlNJNjlFVUFWNHZtUnZUa1ZSZ0dibWVFZE5RWElpMVJlVmt3Mzk3TjY1QVVQMm1VZ3pUR2dVZ0FRVzZ5Mi1KMEczdk5LbzdtWjZ5MWdJMkU4WkFHeDRpWk5SV2gtcmtQb2E2OHpPX3czWW9iVnNSdUcyclp1T2x0Rm1JMUFxaWlSSEtILXZYbzF4a094MHhFc2phYi0wOXZZX2haWlhhMlhpVFFkMjQwUUJqNEpDQQ?oc=5","date":"2025-12-29","type":"trial","source":"Seeking Alpha","summary":"Edgewise: Maintaining Buy On Part D EDG-7500 Data And Next Q2 2026 Catalyst (NASDAQ:EWTX) - Seeking Alpha","headline":"Edgewise: Maintaining Buy On Part D EDG-7500 Data And Next Q2 2026 Catalyst (NASDAQ:EWTX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNdEhvYm1NM2ZLQUVLdi0xYlFLbzRnajNSRzhqRV9QMkFDTnQyaHhEWkNzLUxzamhFb2pVblYxQ05tcmRIN0I1RmIwczRnUWlsM2VFOGRjUTMxT2ItNHJza25NclBQWXNQWUwxc1BSbENQb21nOU1xcmN6NDB4MjJPMnJ0Yi03bFhScWFmTGJ0bF9zb3RTVGtudnVwS3BUZkEtblFueUVIQU8wTDFXdXVJTEdCdWJ4bzdiN3BjclEyMndsWXRqbXVN?oc=5","date":"2025-12-26","type":"regulatory","source":"RTTNews","summary":"Weekly Buzz: FDA OKs Roche's Lunsumio VELO; It's No For Tolbrutinib; BioMarin, SNY Open Wallets - RTTNews","headline":"Weekly Buzz: FDA OKs Roche's Lunsumio VELO; It's No For Tolbrutinib; BioMarin, SNY Open Wallets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxQdTlxTGg1bFVlN3BkcWFuNDI1R19RRENYRWJEYnFSTWozOEFZS3hLc09hRHl0bGkxQXd2akM3MTMzd2NfTnlnTzBveXFybWkwQ1VROVlmUFdHWWRHMFZGWDc0VlBfemJueVcyTFR3RDEyaDFWMV80WkpUX3pHMnRCSGM0a0lJcFNsRzEyQUl6SW9pZVBQaXFqSE9nZEZSaFhSUGJ6Ymt4aTV5NWlERzNDU1BMVjJBM2hFNklOcFZyazNkTWdMQk0zakhxQWh6VkN0VXp1Y0NmeVJtcWRNb0hycE81X0toc1RpRjkyMGJhWVRfLXlCT1VUMTZHS3RkdmJodndNYVF4QTlIcnZKSWxIRHhNZVVQVzYz?oc=5","date":"2025-12-19","type":"earnings","source":"Benzinga","summary":"Carnival Posts Strong Q4 Earnings, Joins Amicus Therapeutics, Biomarin Pharmaceutical And Other Big Stock - Benzinga","headline":"Carnival Posts Strong Q4 Earnings, Joins Amicus Therapeutics, Biomarin Pharmaceutical And Other Big Stock","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxNamhFVjBWekF2Mjc3cHpia0tNdkhXUlM3YkgtcHZ1NkNsMmtFSnNsRGZmNFM4a29iTUVKLUdjSWtHUjhReVdyd2RMLUdiQkQwVWpfc1pkS0FUVXo0d1NkbWhET2JtMHRoMnRTVi1oUjhLdWQyaWpKYWtscjlRRS1qNmZOUHU2MDhXdUdwWDg1UE5PTFMtWTdGYlJnZXJwbjVRc3hqaVFuNkJ1NjdUTGZPY19NaTUzdzdyZ3dPaEdaVDFlZ2lKNTBrclFSUml0NFJEWE44aWl2X1dZME9ZeUJITHQzZmVLb0JiWFJ6WC1ydi1BM1JLOWl2cWpweHRTdw?oc=5","date":"2025-12-19","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on Top Healthcare Stocks: Novan (NOVN), 4D Molecular Therapeutics (FDMT) - The Globe and Mail","headline":"Analysts Are Bullish on Top Healthcare Stocks: Novan (NOVN), 4D Molecular Therapeutics (FDMT)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNODBheXN6VTd1T00wSlhYX0MwME91MlR0WEJYTXZ1VVRWYy1zMExRbHY5LUlmamR2Y0tzaUNMZkkyNUNwTkFFeVFXa2J5NG16ZENETHc5V1lXMHNGdTFpel9tUnVuYmdDQUFWUHlUanhOc3FNRV9NZ19iNnRleGpqR3E2a3d2VGNZZVl3VjZjTDljYlBycWdhM3RPVmtISlFQUmJmUEF1Z1o4RjMtV0VVc2YybzgtX2ZoaFpGUllZQXk2Nl81aWFyTVRqSU9FUWlhelk4TVBHbHQyMEhpc3BzYlRXMkZvQTR2aGMyVlk0QmtEcXlu?oc=5","date":"2025-12-11","type":"pipeline","source":"European Medical Journal","summary":"Breakthroughs in Becker: Unveiling New Natural History Insights and a Novel Agent’s Clinical Progress - European Medical Journal","headline":"Breakthroughs in Becker: Unveiling New Natural History Insights and a Novel Agent’s Clinical Progress","sentiment":"neutral"},{"date":"2025-11-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOakZZeHpzd0dMZkpLSE9ieExBTU93QWs1SEV2Q1I4Smp2bW1jYm5JRjRlTHdNZ0hxcnlVdEVGZTh0RFpHb0JjZkdyN1YtR3hZVHN1ZlBLWHM3TnNNZGdRWlFWYUhHalVYcUk3cnIzV3NBdVcxckM5cW0tNnRsZWgzZ3BxVGNqTTd0aU5vTzJOOXVFVFVZR1lFMnVLQl9DMGVtaEs4QW9BbWs?oc=5","date":"2025-11-13","type":"pipeline","source":"BioCentury","summary":"New heads of neuro, immunology at Lilly, and more biopharma moves - BioCentury","headline":"New heads of neuro, immunology at Lilly, and more biopharma moves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPZGNJeVdzOUZST1k0c0dtVXJBb3ZIeU9FWFoyczB2LUgwcE5BX24yT0stZ0R2c0hmMFFRVnZmMEttVm5DdkdFSVpuaUhVdDF5VzlfYzJ5RUo2WnRpZUFwR0xXUTlCMUZRMGdmOTdTSTBISF9SR2NNVUZ6dHRQWVF2UE9hRFU4SUF6Wnh1VnIxaElTbzY5QVk1Sm53Y3lIRDZyaUgxcGVn?oc=5","date":"2025-04-02","type":"trial","source":"Investopedia","summary":"Edgewise Therapeutics Stock Plummets on Drug Trial 'Adverse Events' - Investopedia","headline":"Edgewise Therapeutics Stock Plummets on Drug Trial 'Adverse Events'","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPT25sTWNYUVY4ZVZtRkJxc1FmNFpCQUpkLUstQnZpSTNpaW1jaXp1T1V0ZW9wa2IzaWVnR293SHRtOThJX3ZyUlFCZzVnM1otay1FQzI5bEJLMElaUVZWZlpvc2cxaEFLSHRBMkU2MzZJUV9uQ3JtekRvR3YxaGFKZVA5NndnQQ?oc=5","date":"2024-05-08","type":"pipeline","source":"BizWest","summary":"Edgewise adds biotech industry adviser to board - BizWest","headline":"Edgewise adds biotech industry adviser to board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPRHVvbVJUMi1xaTI0NXQweVFIaDliODlwUlYtNHVuMkYyOTJUYy1IT3RfSFpCY2lkMUJHWXVWcDhTR1YzenpScUgyR3A3SGZMcE56by01WFM3Q2w2UzZ1T3pNRThibl9ZY2JldkRxLWROWXJWYTR0V3VfekhLcWphakRCV3RRTmRvc2Q2Y3VLZ1FKUmhna1VRYVFZZFRTQWhsTmdHZmZTR0RPTk1pSWlYTndmbmdEQmR2ZkFZYTU3Z1k?oc=5","date":"2021-03-25","type":"pipeline","source":"Business Wire","summary":"Edgewise Therapeutics Announces Pricing of Initial Public Offering - Business Wire","headline":"Edgewise Therapeutics Announces Pricing of Initial Public Offering","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":151389000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-167795000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":61148000,"cashHistory":[],"totalAssets":552603000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}